Global Aging And Genomics Will Expand RNAi Treatment Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
05 Aug 25
Updated
09 Aug 25
AnalystHighTarget's Fair Value
US$80.00
75.0% undervalued intrinsic discount09 Aug
US$19.99
1Y
-11.9%7D
22.6%